Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-28

Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing telmisartan to valsartan in adults with stage 1–2 hypertension; eight-week, double-blind, placebo-controlled forced-titration…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED